Global Direct Oral Anticoagulants (DOACs) Device Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Direct Oral Anticoagulants (DOACs) Device Global Market Report 2025

Name: Direct Oral Anticoagulants (DOACs) Device Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product (Factor Xa Inhibitors, Direct Thrombin Inhibitors), By Disease (Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, Heart Attacks, Post-Surgical Thromboprophylaxis, Other Diseases), By Application (Stroke Prevention, Venous Thromboembolism Prevention, Treatment Of Acute Thrombotic Events, Long-Term Prophylaxis, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Homecare Settings, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Direct Oral Anticoagulants (DOACs) Device Market Overview

• Direct Oral Anticoagulants (DOACs) Device market size has reached to $30.10 billion in 2024

• Expected to grow to $45.65 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%

• Growth Driver: Rising Cardiovascular Disease Prevalence Fueling The Growth Of The Market Due To Increasing Need For Effective Stroke And Clot Prevention

• Market Trend: Innovative Automated Assays Enhance Accuracy And Efficiency In Anticoagulant Monitoring

• North America was the largest region in 2024.

What Is Covered Under Direct Oral Anticoagulants (DOACs) Device Market?

Direct oral anticoagulants device refers to medical instruments or diagnostic tools used to monitor and manage the blood-thinning effects of direct oral anticoagulant medications. These devices help clinicians assess drug levels and anticoagulation status in patients taking medications such as rivaroxaban, apixaban, edoxaban, or dabigatran, ensuring safe and effective treatment.

The main products of direct oral anticoagulants (DOACs) device are factor Xa inhibitors and direct thrombin inhibitors. Factor Xa inhibitors refer to a class of anticoagulant medications that work by selectively blocking the activity of factor Xa, an essential enzyme in the blood coagulation cascade, thereby preventing the formation of harmful blood clots. These drugs are commonly used to manage conditions such as atrial fibrillation, deep vein thrombosis, pulmonary embolism, heart attacks, post-surgical thromboprophylaxis, and other diseases. Their applications span across stroke prevention, venous thromboembolism prevention, treatment of acute thrombotic events, long-term prophylaxis, and others, and are used by several end users, including hospitals, ambulatory surgical centers, specialty clinics, homecare settings, and others.

Direct Oral Anticoagulants (DOACs) Device Market Size and growth rate 2025 to 2029: Graph

What Is The Direct Oral Anticoagulants (DOACs) Device Market Size 2025 And Growth Rate?

What Is The Direct Oral Anticoagulants (DOACs) Device Market Growth Forecast?

The direct oral anticoagulants (DOACs) device market size is expected to see strong growth in the next few years. It will grow to $45.65 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growing adoption of personalized medicine, increasing preference for home-based anticoagulant management, rising demand for rapid diagnostic tools, expanding awareness regarding stroke prevention, and expanding healthcare infrastructure in emerging markets. Major trends in the forecast period include integration of smart sensors in monitoring devices, development of point-of-care direct oral anticoagulant testing tools, continuous innovation in drug delivery mechanisms, integration into routine clinical workflows, and technological advancements in patient compliance tools.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Direct Oral Anticoagulants (DOACs) Device Market Segmented?

1) By Product: Factor Xa Inhibitors, Direct Thrombin Inhibitors

2) By Disease: Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, Heart Attacks, Post-Surgical Thromboprophylaxis, Other Diseases

3) By Application: Stroke Prevention, Venous Thromboembolism Prevention, Treatment Of Acute Thrombotic Events, Long-Term Prophylaxis, Other Applications

4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Factor Xa Inhibitors: Rivaroxaban Monitoring Devices, Apixaban Monitoring Devices, Edoxaban Monitoring Devices, Betrixaban Monitoring Devices

2) By Direct Thrombin Inhibitors: Dabigatran Etexilate, Dabigatran Mesylate

What Is Driving The Direct Oral Anticoagulants (DOACs) Device Market? Rising Cardiovascular Disease Prevalence Fueling The Growth Of The Market Due To Increasing Need For Effective Stroke And Clot Prevention

The increasing prevalence of cardiovascular disorders is expected to propel the growth of the direct oral anticoagulants (DOACs) device market going forward. Cardiovascular disorders refer to a range of conditions that impact the heart and blood vessels, often leading to issues such as heart attacks, strokes, or other circulatory system problems. Cardiovascular disorders are rising due to increasingly sedentary lifestyles, which lead to weight gain, elevated blood pressure, and weakened cardiovascular function over time. Direct oral anticoagulants (DOACs) help manage cardiovascular disorders by effectively lowering the risk of stroke and blood clots in patients with atrial fibrillation, offering reliable anticoagulation without the need for frequent blood tests. For instance, in January 2025, according to the American Heart Association, a US-based nonprofit organization, cardiovascular disease was responsible for 941,652 deaths in the US in 2022, which is over 10,000 more than the 931,578 deaths attributed to it in 2021. Therefore, the increasing prevalence of cardiovascular disorders is driving the growth of the direct oral anticoagulants (DOACs) device industry.

Who Are The Major Players In The Global Direct Oral Anticoagulants (DOACs) Device Market?

Major companies operating in the direct oral anticoagulants (DOACs) device market are Pfizer Inc., Roche Diagnostics Corporation, Bristol-Myers Squibb Company, Siemens Healthcare GmbH, Becton Dickinson And Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Daiichi Sankyo Co. Ltd, Sysmex Corporation, Dr. Reddy’s Laboratories Limited, Werfen S.A., Alembic Pharmaceuticals Limited, Diagnostica Stago SAS, Helena Laboratories Corporation, iLine Microsystems S.L., Technoclone GmbH, Anthos Therapeutics Inc., FLoBio LLC, Perosphere Technologies Inc., and DOASENSE GmbH.

What Are The Key Trends Of The Global Direct Oral Anticoagulants (DOACs) Device Market? Innovative Automated Assays Enhance Accuracy And Efficiency In Anticoagulant Monitoring

Major companies operating in the direct oral anticoagulants (DOACs) device market are focusing on developing advanced solutions, such as automated coagulation assays, to improve the accuracy, efficiency, and consistency of direct oral anticoagulant level monitoring in clinical laboratories. Automated coagulation assays are laboratory tests performed by machines that measure how quickly blood clots to help diagnose bleeding or clotting disorders. For instance, in February 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, launched three new coagulation tests specifically designed for Factor Xa inhibitors. These tests enhance clinicians' ability to accurately evaluate the anticoagulation status of patients taking direct Factor Xa inhibitors such as rivaroxaban and apixaban. They aid clinical decision-making by precisely measuring the anti-Xa activity of apixaban, edoxaban, rivaroxaban, and heparin in critical scenarios like bleeding, overdose, or urgent surgery. Utilizing Roche’s reagent cassette technology on cobas t analyzers, these automated tests deliver high-quality results, minimize manual handling, and streamline laboratory workflow efficiency.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Direct Oral Anticoagulants (DOACs) Device Market? Perosphere Technologies And Correct Medical Expand Access To DOAC Testing Devices In Germany

In July 2024, Perosphere Technologies Inc., a US-based medical diagnostics company, partnered with CoRRect Medical to exclusively distribute its reagent-free point-of-care coagulometer in Germany. With this partnership, Perosphere aims to address unmet needs in coagulation testing by enabling rapid, bedside diagnosis of anticoagulation status, particularly for patients on direct oral anticoagulants, thus improving treatment decisions, enhancing patient outcomes, and reducing healthcare costs. CoRRect Medical is a Germany-based medical device company.

What Is The Regional Outlook For The Global Direct Oral Anticoagulants (DOACs) Device Market?

North America was the largest region in the direct oral anticoagulants (DOACs) device market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Direct Oral Anticoagulants (DOACs) Device Market?

The direct oral anticoagulants (DOACs) device market consists of sales of drug delivery devices, monitoring devices, adherence management tools and digital health platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Direct Oral Anticoagulants (DOACs) Device Industry?

The direct oral anticoagulants (doacs) device market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the direct oral anticoagulants (doacs) device industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Direct Oral Anticoagulants DOACs Device Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$32.80 billion
Revenue Forecast In 2034	$45.65 billion
Growth Rate	CAGR of 8.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Product, Disease, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Roche Diagnostics Corporation, Bristol-Myers Squibb Company, Siemens Healthcare GmbH, Becton Dickinson And Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Daiichi Sankyo Co. Ltd, Sysmex Corporation, Dr. Reddy’s Laboratories Limited, Werfen S.A., Alembic Pharmaceuticals Limited, Diagnostica Stago SAS, Helena Laboratories Corporation, iLine Microsystems S.L., Technoclone GmbH, Anthos Therapeutics Inc., FLoBio LLC, Perosphere Technologies Inc., and DOASENSE GmbH.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Direct Oral Anticoagulants (DOACs) Device Market Characteristics

3. Direct Oral Anticoagulants (DOACs) Device Market Trends And Strategies

4. Direct Oral Anticoagulants (DOACs) Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Direct Oral Anticoagulants (DOACs) Device Growth Analysis And Strategic Analysis Framework

5.1. Global Direct Oral Anticoagulants (DOACs) Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Direct Oral Anticoagulants (DOACs) Device Market Growth Rate Analysis

5.4. Global Direct Oral Anticoagulants (DOACs) Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Direct Oral Anticoagulants (DOACs) Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Direct Oral Anticoagulants (DOACs) Device Total Addressable Market (TAM)

6. Direct Oral Anticoagulants (DOACs) Device Market Segmentation

6.1. Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Factor Xa Inhibitors

Direct Thrombin Inhibitors

6.2. Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Atrial Fibrillation

Deep Vein Thrombosis

Pulmonary Embolism

Heart Attacks

Post-Surgical Thromboprophylaxis

Other Diseases

6.3. Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stroke Prevention

Venous Thromboembolism Prevention

Treatment Of Acute Thrombotic Events

Long-Term Prophylaxis

Other Applications

6.4. Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Homecare Settings

Other End Users

6.5. Global Direct Oral Anticoagulants (DOACs) Device Market, Sub-Segmentation Of Factor Xa Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rivaroxaban Monitoring Devices

Apixaban Monitoring Devices

Edoxaban Monitoring Devices

Betrixaban Monitoring Devices

6.6. Global Direct Oral Anticoagulants (DOACs) Device Market, Sub-Segmentation Of Direct Thrombin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dabigatran Etexilate

Dabigatran Mesylate

7. Direct Oral Anticoagulants (DOACs) Device Market Regional And Country Analysis

7.1. Global Direct Oral Anticoagulants (DOACs) Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Direct Oral Anticoagulants (DOACs) Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Direct Oral Anticoagulants (DOACs) Device Market

8.1. Asia-Pacific Direct Oral Anticoagulants (DOACs) Device Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Direct Oral Anticoagulants (DOACs) Device Market

9.1. China Direct Oral Anticoagulants (DOACs) Device Market Overview

9.2. China Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Direct Oral Anticoagulants (DOACs) Device Market

10.1. India Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Direct Oral Anticoagulants (DOACs) Device Market

11.1. Japan Direct Oral Anticoagulants (DOACs) Device Market Overview

11.2. Japan Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Direct Oral Anticoagulants (DOACs) Device Market

12.1. Australia Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Direct Oral Anticoagulants (DOACs) Device Market

13.1. Indonesia Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Direct Oral Anticoagulants (DOACs) Device Market

14.1. South Korea Direct Oral Anticoagulants (DOACs) Device Market Overview

14.2. South Korea Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Direct Oral Anticoagulants (DOACs) Device Market

15.1. Western Europe Direct Oral Anticoagulants (DOACs) Device Market Overview

15.2. Western Europe Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Direct Oral Anticoagulants (DOACs) Device Market

16.1. UK Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Direct Oral Anticoagulants (DOACs) Device Market

17.1. Germany Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Direct Oral Anticoagulants (DOACs) Device Market

18.1. France Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Direct Oral Anticoagulants (DOACs) Device Market

19.1. Italy Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Direct Oral Anticoagulants (DOACs) Device Market

20.1. Spain Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Direct Oral Anticoagulants (DOACs) Device Market

21.1. Eastern Europe Direct Oral Anticoagulants (DOACs) Device Market Overview

21.2. Eastern Europe Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Direct Oral Anticoagulants (DOACs) Device Market

22.1. Russia Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Direct Oral Anticoagulants (DOACs) Device Market

23.1. North America Direct Oral Anticoagulants (DOACs) Device Market Overview

23.2. North America Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Direct Oral Anticoagulants (DOACs) Device Market

24.1. USA Direct Oral Anticoagulants (DOACs) Device Market Overview

24.2. USA Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Direct Oral Anticoagulants (DOACs) Device Market

25.1. Canada Direct Oral Anticoagulants (DOACs) Device Market Overview

25.2. Canada Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Direct Oral Anticoagulants (DOACs) Device Market

26.1. South America Direct Oral Anticoagulants (DOACs) Device Market Overview

26.2. South America Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Direct Oral Anticoagulants (DOACs) Device Market

27.1. Brazil Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Direct Oral Anticoagulants (DOACs) Device Market

28.1. Middle East Direct Oral Anticoagulants (DOACs) Device Market Overview

28.2. Middle East Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Direct Oral Anticoagulants (DOACs) Device Market

29.1. Africa Direct Oral Anticoagulants (DOACs) Device Market Overview

29.2. Africa Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Direct Oral Anticoagulants (DOACs) Device Market Competitive Landscape And Company Profiles

30.1. Direct Oral Anticoagulants (DOACs) Device Market Competitive Landscape

30.2. Direct Oral Anticoagulants (DOACs) Device Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis

31. Direct Oral Anticoagulants (DOACs) Device Market Other Major And Innovative Companies

31.1. Boehringer Ingelheim International GmbH

31.2. Teva Pharmaceutical Industries Limited

31.3. Daiichi Sankyo Co. Ltd

31.4. Sysmex Corporation

31.5. Dr. Reddy’s Laboratories Limited

31.6. Werfen S.A.

31.7. Alembic Pharmaceuticals Limited

31.8. Diagnostica Stago SAS

31.9. Helena Laboratories Corporation

31.10. iLine Microsystems S.L.

31.11. Technoclone GmbH

31.12. Anthos Therapeutics Inc.

31.13. FLoBio LLC

31.14. Perosphere Technologies Inc.

31.15. DOASENSE GmbH

32. Global Direct Oral Anticoagulants (DOACs) Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Direct Oral Anticoagulants (DOACs) Device Market

34. Recent Developments In The Direct Oral Anticoagulants (DOACs) Device Market

35. Direct Oral Anticoagulants (DOACs) Device Market High Potential Countries, Segments and Strategies

35.1 Direct Oral Anticoagulants (DOACs) Device Market In 2029 - Countries Offering Most New Opportunities

35.2 Direct Oral Anticoagulants (DOACs) Device Market In 2029 - Segments Offering Most New Opportunities

35.3 Direct Oral Anticoagulants (DOACs) Device Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Direct Oral Anticoagulants (DOACs) Device Market, Sub-Segmentation Of Factor Xa Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Direct Oral Anticoagulants (DOACs) Device Market, Sub-Segmentation Of Direct Thrombin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Direct Oral Anticoagulants (DOACs) Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Direct Oral Anticoagulants (DOACs) Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Pfizer Inc. Financial Performance

Table 78: Roche Diagnostics Corporation Financial Performance

Table 79: Bristol-Myers Squibb Company Financial Performance

Table 80: Siemens Healthcare GmbH Financial Performance

Table 81: Becton Dickinson And Company Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Direct Oral Anticoagulants (DOACs) Device Market, Sub-Segmentation Of Factor Xa Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Direct Oral Anticoagulants (DOACs) Device Market, Sub-Segmentation Of Direct Thrombin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Direct Oral Anticoagulants (DOACs) Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Direct Oral Anticoagulants (DOACs) Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Disease , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Direct Oral Anticoagulants (DOACs) Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Pfizer Inc. Financial Performance

Figure 78: Roche Diagnostics Corporation Financial Performance

Figure 79: Bristol-Myers Squibb Company Financial Performance

Figure 80: Siemens Healthcare GmbH Financial Performance

Figure 81: Becton Dickinson And Company Financial Performance

Emerging Trends Redefining the Non-Invasive Aesthetic Treatment Market Landscape: Hybrid Imaging Technologies Transforming Nuclear Medical Imaging

Top Trends Driving Innovation and Change in the Nuclear Medicine Diagnostics Market: Advancements In Nuclear Medicine Diagnostics Define The Future Of Patient-Centric Solutions

Market Trends Influencing Strategic Decisions in the Operating Room Equipment Industry: Rising Popularity Of Hybrid Operating Rooms Revolutionizes Surgical Practices Worldwide

Key Developments and Trends Steering the Orthopedic Devices Market Forward: Advancements In Non-Surgical Therapies Limit Orthopedic Devices Market Growth

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Explore strategic insights and forecasts in the global virtual biopsy market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Global Nuclear Reactor Market.

Machine Learning Operations Global Market Report 2025 – By Deployment Type (On-premise, Cloud, Other Type Of Deployment), By Organization Size (Large Enterprises, Small and Medium-sized Enterprises), By Industry Vertical...

Financial Services Global Market Report 2025 – By Type (Lending And Payments, Insurance, Reinsurance And Insurance Brokerage, Investments, Foreign Exchange Services), By Size Of Business (Small And Medium Business, Large...

Machine Learning Global Market Report 2025 – By Component Outlook ( Hardware, Software), By Deployment (Cloud, On-Premises), By Type (Large Enterprises, Small and Medium Enterprise), By End-user (Healthcare, Retail, BFSI...

Financial Analytics Global Market Report 2025 – By Component( Solution), By Deployment Mode( On-Premise, Cloud), By Organization Size( Large Enterprises, Small & Medium Sized Enterprises), By Application( Wealth Manageme...

Machine Learning (ML) in The Pharmaceutical Industry Global Market Report 2025 – By Component (Solution, Services), By Component (Cloud, On-premise), By Enterprise Size (Small and Medium Enterprises (SMEs), Large Enterpr...

Artificial Intelligence In Accounting Global Market Report 2025 – By Component (Solutions, Services), By Technology (Machine Learning (ML) And Deep Learning, Natural Language Processing), By Deployment Mode (Cloud, On-Pr...

Financial Services Software Global Market Report 2025 – By Component (Software, Service), By Type (Cloud-based, On-Premise), By Application (Large Enterprises, Small And Medium-Sized Enterprises (SMEs)) – Impact of Tarif...

Frequently Asked Questions

What is the definition of the Direct Oral Anticoagulants DOACs Device market?

How will the Direct Oral Anticoagulants DOACs Device market drivers and restraints affect the market dynamics? What forces will shape the Direct Oral Anticoagulants DOACs Device industry going forward?

The market major growth driver - Rising Cardiovascular Disease Prevalence Fueling The Growth Of The Market Due To Increasing Need For Effective Stroke And Clot Prevention. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Direct Oral Anticoagulants DOACs Device market?

The direct oral anticoagulants (DOACs) device market size has grown strongly in recent years. It will grow from $30.10 billion in 2024 to $32.80 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to the rising prevalence of cardiovascular disorders, the increasing incidence of atrial fibrillation, the growing awareness about stroke prevention, the increasing anticoagulant prescriptions, and the expanding geriatric population. The direct oral anticoagulants (DOACs) device market size is expected to see strong growth in the next few years. It will grow to $45.65 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growing adoption of personalized medicine, increasing preference for home-based anticoagulant management, rising demand for rapid diagnostic tools, expanding awareness regarding stroke prevention, and expanding healthcare infrastructure in emerging markets. Major trends in the forecast period include integration of smart sensors in monitoring devices, development of point-of-care direct oral anticoagulant testing tools, continuous innovation in drug delivery mechanisms, integration into routine clinical workflows, and technological advancements in patient compliance tools. For further insights on this market, request a sample here

How is the Direct Oral Anticoagulants DOACs Device market segmented?

The direct oral anticoagulants (DOACs) device market covered in this report is segmented
1) By Product: Factor Xa Inhibitors, Direct Thrombin Inhibitors
2) By Disease: Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, Heart Attacks, Post-Surgical Thromboprophylaxis, Other Diseases
3) By Application: Stroke Prevention, Venous Thromboembolism Prevention, Treatment Of Acute Thrombotic Events, Long-Term Prophylaxis, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Homecare Settings, Other End Users Subsegments:
1) By Factor Xa Inhibitors: Rivaroxaban Monitoring Devices, Apixaban Monitoring Devices, Edoxaban Monitoring Devices, Betrixaban Monitoring Devices
2) By Direct Thrombin Inhibitors: Dabigatran Etexilate, Dabigatran Mesylate For further insights on this market, request a sample here

Which region has the largest share of the Direct Oral Anticoagulants DOACs Device market? What are the other regions covered in the report?

North America was the largest region in the direct oral anticoagulants (DOACs) device market in 2024. The regions covered in the direct oral anticoagulants (DOACs) device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Direct Oral Anticoagulants DOACs Device market?

What are the key trends in the Direct Oral Anticoagulants DOACs Device market?

Major trends in this market include Innovative Automated Assays Enhance Accuracy And Efficiency In Anticoagulant Monitoring. For further insights on this market, request a sample here.